Invention Grant
- Patent Title: Methods for diagnosing cancer
-
Application No.: US13141787Application Date: 2009-12-21
-
Publication No.: US09624548B2Publication Date: 2017-04-18
- Inventor: Richard Morgan , Hardev Pandha
- Applicant: Richard Morgan , Hardev Pandha
- Applicant Address: GB Guildford, Surrey
- Assignee: The University of Surrey
- Current Assignee: The University of Surrey
- Current Assignee Address: GB Guildford, Surrey
- Agency: McCarter & English, LLP
- Agent Maria Laccotripe Zacharakis
- Priority: GB0823445.2 20081223
- International Application: PCT/GB2009/002926 WO 20091221
- International Announcement: WO2010/073001 WO 20100701
- Main IPC: C12Q1/68
- IPC: C12Q1/68
Abstract:
Described are bladder cancer specific biomarkers and lung cancer specific biomarkers comprising the nucleic acid sequence of the Engrailed-2 (EN2) gene or the amino acid sequence of the encoded EN2 protein. Also described are uses of the biomarkers in the treatment, diagnosis, monitoring and imaging of bladder cancer and lung cancer.
Public/Granted literature
- US20120020888A1 BIOMARKER Public/Granted day:2012-01-26
Information query
